{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:12:53Z","timestamp":1784106773568,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95875-1","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:32:21Z","timestamp":1744738341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India"],"prefix":"10.1038","volume":"15","author":[{"given":"Srilagna","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirvika","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbashri","family":"Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswabandhu","family":"Bankura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Prakash","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhajit","family":"Malakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunirmal","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudakshina","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"95875_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"95875_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G","volume":"183","author":"G Kovacs","year":"1997","unstructured":"Kovacs, G. et al. The Heidelberg classification of renal cell tumours. J. Pathol. 183, 131\u2013133 (1997).","journal-title":"J. Pathol."},{"key":"95875_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri, T. K. & Motzer, R. J. Systemic therapy for metastatic Renal-Cell carcinoma. N. Engl. J. Med. 376, 354\u2013366 (2017).","journal-title":"N. Engl. J. Med."},{"key":"95875_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers. 3, 1\u201319 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"95875_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11912-019-0752-z","volume":"21","author":"J Fallah","year":"2019","unstructured":"Fallah, J. & Rini, B. I. HIF inhibitors: status of current clinical development. Curr. Oncol. Rep. 21, 6 (2019).","journal-title":"Curr. Oncol. Rep."},{"key":"95875_CR6","doi-asserted-by":"crossref","unstructured":"Choueiri, T. K. et al. Von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. J. Urol. (2008).","DOI":"10.1016\/j.juro.2008.05.015"},{"key":"95875_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/jco.jco_5_22","volume":"5","author":"S Bhagat","year":"2022","unstructured":"Bhagat, S., Khatri, N., Patil, S. & Barkate, H. V. Role of axitinib and other tyrosine kinase inhibitors in the management of metastatic renal cell carcinoma. J. Curr. Oncol. 5, 35 (2022).","journal-title":"J. Curr. Oncol."},{"key":"95875_CR8","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1016\/j.febslet.2009.10.070","volume":"583","author":"E Leonardi","year":"2009","unstructured":"Leonardi, E., Murgia, A. & Tosatto, S. c. E. Adding structural information to the von Hippel\u2013Lindau (VHL) tumor suppressor interaction network. FEBS Lett. 583, 3704\u20133710 (2009).","journal-title":"FEBS Lett."},{"key":"95875_CR9","doi-asserted-by":"publisher","first-page":"e162480","DOI":"10.1172\/JCI162480","volume":"132","author":"G William","year":"2022","unstructured":"William, G. & Kaelin, J. Von Hippel\u2013Lindau disease: insights into oxygen sensing, protein degradation, and cancer. J. Clin. Investig. 132, e162480 (2022).","journal-title":"J. Clin. Investig."},{"key":"95875_CR10","first-page":"901","volume":"25","author":"TA Cardote","year":"2017","unstructured":"Cardote, T. A., Gadd, M. S. & Ciulli, A. Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex. Structure(London England:1993). 25, 901 (2017).","journal-title":"Structure(London England:1993)"},{"key":"95875_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh, M. et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the \u03b2-domain of the von Hippel\u2013Lindau protein. Nat. Cell. Biol. 2, 423\u2013427 (2000).","journal-title":"Nat. Cell. Biol."},{"key":"95875_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","volume":"23","author":"C Shen","year":"2012","unstructured":"Shen, C., William, G. & Kaelin, J. The VHL\/HIF axis in clear cell renal carcinoma. Sem. Cancer Biol. 23, 18 (2012).","journal-title":"Sem. Cancer Biol."},{"key":"95875_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/path.2310","volume":"214","author":"K Struckmann","year":"2008","unstructured":"Struckmann, K. et al. pVHL co-ordinately regulates CXCR4\/CXCL12 and MMP2\/MMP9 expression in human clear-cell renal cell carcinoma. J. Pathol. 214, 464\u2013471 (2008).","journal-title":"J. Pathol."},{"key":"95875_CR14","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.2174\/138161209789649394","volume":"15","author":"VH Haase","year":"2009","unstructured":"Haase, V. H. The VHL tumor suppressor: master regulator of HIF. Curr. Pharm. Design. 15, 3895 (2009).","journal-title":"Curr. Pharm. Design"},{"key":"95875_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u2013275 (1999).","journal-title":"Nature"},{"key":"95875_CR16","doi-asserted-by":"publisher","first-page":"27444","DOI":"10.1074\/jbc.272.43.27444","volume":"272","author":"Y Takagi","year":"1997","unstructured":"Takagi, Y., Pause, A., Conaway, R. C. & Conaway, J. W. Identification of Elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein**. J. Biol. Chem. 272, 27444\u201327449 (1997).","journal-title":"J. Biol. Chem."},{"key":"95875_CR17","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1073\/pnas.97.15.8507","volume":"97","author":"AR Schoenfeld","year":"2000","unstructured":"Schoenfeld, A. R., Davidowitz, E. J. & Burk, R. D. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc. Natl. Acad. Sci. 97, 8507\u20138512 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"95875_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola, P. et al. Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-Regulated Prolyl hydroxylation. Science 292, 468\u2013472 (2001).","journal-title":"Science"},{"key":"95875_CR19","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1093\/hmg\/ddac066","volume":"31","author":"A Andreou","year":"2022","unstructured":"Andreou, A. et al. Elongin C (ELOC\/TCEB1)-associated von Hippel\u2013Lindau disease. Hum. Mol. Genet. 31, 2728 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"95875_CR20","doi-asserted-by":"crossref","unstructured":"Kim, E. & Zschiedrich, S. Renal cell carcinoma in von Hippel\u2013Lindau Disease\u2014From tumor genetics to novel therapeutic strategies. Front. Pediatr. 6 (2018).","DOI":"10.3389\/fped.2018.00016"},{"key":"95875_CR21","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1158\/1078-0432.CCR-09-2131","volume":"15","author":"AC Young","year":"2009","unstructured":"Young, A. C. et al. Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clin. Cancer Res. 15, 7582\u20137592 (2009).","journal-title":"Clin. Cancer Res."},{"key":"95875_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrclinonc.2010.42","volume":"7","author":"L Gossage","year":"2010","unstructured":"Gossage, L. & Eisen, T. Alterations in VHL as potential biomarkers in renal-cell carcinoma. Nat. Rev. Clin. Oncol. 7, 277\u2013288 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"95875_CR23","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-05-3074","volume":"66","author":"RE Banks","year":"2006","unstructured":"Banks, R. E. et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res. 66, 2000\u20132011 (2006).","journal-title":"Cancer Res."},{"key":"95875_CR24","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","volume":"14","author":"ML Nickerson","year":"2008","unstructured":"Nickerson, M. L. et al. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin. Cancer Res. 14, 4726\u20134734 (2008).","journal-title":"Clin. Cancer Res."},{"key":"95875_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/gcc.10054","volume":"34","author":"K Kondo","year":"2002","unstructured":"Kondo, K. et al. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Genes Chromosomes Cancer. 34, 58\u201368 (2002).","journal-title":"Genes Chromosomes Cancer"},{"key":"95875_CR26","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1681\/ASN.2015121335","volume":"27","author":"SL Hu","year":"2016","unstructured":"Hu, S. L. et al. The nephrologist\u2019s tumor: basic biology and management of renal cell carcinoma. J. Am. Soc. Nephrol. 27, 2227\u20132237 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"95875_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","volume":"132","author":"P Chittiboina","year":"2015","unstructured":"Chittiboina, P. & Lonser, R. R. Von Hippel\u2013Lindau disease. Handb. Clin. Neurol. 132, 139\u2013156 (2015).","journal-title":"Handb. Clin. Neurol."},{"key":"95875_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11912-009-0015-5","volume":"11","author":"CL Cowey","year":"2009","unstructured":"Cowey, C. L. & Rathmell, W. K. VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy. Curr. Oncol. Rep. 11, 94\u2013101 (2009).","journal-title":"Curr. Oncol. Rep."},{"key":"95875_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/path.1034","volume":"196","author":"P Schraml","year":"2002","unstructured":"Schraml, P. et al. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J. Pathol. 196, 186\u2013193 (2002).","journal-title":"J. Pathol."},{"key":"95875_CR30","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.4103\/0366-6999.161353","volume":"128","author":"Y Song","year":"2015","unstructured":"Song, Y., Huang, J., Shan, L. & Zhang, H. T. Analyses of potential predictive markers and response to targeted therapy in patients with advanced Clear-cell renal cell carcinoma. Chin. Med. J. 128, 2026\u20132033 (2015).","journal-title":"Chin. Med. J."},{"key":"95875_CR31","unstructured":"Genotype\u2013phenotype correlation in. Von Hippel-Lindau disease - Reich \u2013\u20092021 - Acta Ophthalmologica - Wiley Online Library."},{"key":"95875_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/jmedgenet-2019-106336","volume":"57","author":"H Xie","year":"2020","unstructured":"Xie, H. et al. Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (VHL) disease based on the Elongin C binding site: a large retrospective study. J. Med. Genet. 57, 744\u2013751 (2020).","journal-title":"J. Med. Genet."},{"key":"95875_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan, W. M. & Ricketts, C. J. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat. Reviews Urol. 16, 539\u2013552 (2019).","journal-title":"Nat. Reviews Urol."},{"key":"95875_CR34","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12935-018-0661-5","volume":"18","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing. Cancer Cell. Int. 18, 159 (2018).","journal-title":"Cancer Cell. Int."},{"key":"95875_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s43042-022-00338-1","volume":"23","author":"A Dwivedi","year":"2022","unstructured":"Dwivedi, A. et al. Von Hippel\u2013Lindau (VHL) disease and VHL-associated tumors in Indian subjects: VHL gene testing in a resource constraint setting. Egypt. J. Med. Hum. Genet. 23, 126 (2022).","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"95875_CR37","doi-asserted-by":"publisher","first-page":"e61908","DOI":"10.1371\/journal.pone.0061908","volume":"8","author":"AM John","year":"2013","unstructured":"John, A. M. et al. p.Arg82Leu von Hippel-Lindau (VHL) gene mutation among three members of a family with Familial bilateral pheochromocytoma in india: molecular analysis and in Silico characterization. PLOS ONE. 8, e61908 (2013).","journal-title":"PLOS ONE"},{"key":"95875_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10689-017-0058-y","volume":"17","author":"N Lomte","year":"2018","unstructured":"Lomte, N. et al. Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma\/paraganglioma. Fam Cancer. 17, 441\u2013449 (2018).","journal-title":"Fam Cancer"},{"key":"95875_CR39","doi-asserted-by":"crossref","unstructured":"Chandrasekhar, C., Kumar, P. S. & Sarma, P. V. G. K. Novel Mutations in the EPO-R, VHL Genes and a Reported Mutation in EPAS1 Gene in the Congenital Erythrocytosis Patients in a Southern State of India (2019).","DOI":"10.2139\/ssrn.3502366"},{"key":"95875_CR40","doi-asserted-by":"publisher","first-page":"102479","DOI":"10.1016\/j.bcmd.2020.102479","volume":"85","author":"C Chandrasekhar","year":"2020","unstructured":"Chandrasekhar, C., Pasupuleti, S. K. & Sarma, P. V. G. K. Novel mutations in the EPO-R, VHL and EPAS1 genes in the congenital erythrocytosis patients. Blood Cells Molecules Dis. 85, 102479 (2020).","journal-title":"Blood Cells Molecules Dis."},{"key":"95875_CR41","first-page":"66","volume":"4","author":"MZS Al-Khayyat","year":"2016","unstructured":"Al-Khayyat, M. Z. S. & Al-Dabbagh, A. G. A. In Silico prediction and Docking of tertiary structure of LuxI, an inducer synthase of vibrio fischeri. Rep. Biochem. Mol. Biology. 4, 66 (2016).","journal-title":"Rep. Biochem. Mol. Biology"},{"key":"95875_CR42","doi-asserted-by":"publisher","first-page":"100323","DOI":"10.1016\/j.lansea.2023.100323","volume":"24","author":"P Gao","year":"2024","unstructured":"Gao, P. et al. Landscape of cancer clinical trials in India \u2013 a comprehensive analysis of the clinical trial Registry-India. Lancet Reg. Health - Southeast. Asia. 24, 100323 (2024).","journal-title":"Lancet Reg. Health - Southeast. Asia"},{"key":"95875_CR43","doi-asserted-by":"crossref","unstructured":"Sri Guru Ram Das University Of Health Sciences & Jain, N. Cancer Scenario In India. GGS 4, 1\u20133 (2019).","DOI":"10.24966\/GGS-2485\/100014"},{"key":"95875_CR44","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1074\/jbc.M413160200","volume":"280","author":"F Miller","year":"2005","unstructured":"Miller, F., Kentsis, A., Osman, R. & Pan, Z. Q. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL\u00b7Hypoxia-inducible transcription Factor-1\u03b1 complex**. J. Biol. Chem. 280, 7985\u20137996 (2005).","journal-title":"J. Biol. Chem."},{"key":"95875_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins, C. E., Kaelin, W. G. & Pavletich, N. P. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284, 455\u2013461 (1999).","journal-title":"Science"},{"key":"95875_CR46","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1093\/hmg\/ddu321","volume":"23","author":"L Gossage","year":"2014","unstructured":"Gossage, L. et al. An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma. Hum. Mol. Genet. 23, 5976\u20135988 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"95875_CR47","doi-asserted-by":"publisher","first-page":"31128","DOI":"10.1038\/srep31128","volume":"6","author":"F Tabaro","year":"2016","unstructured":"Tabaro, F. et al. VHLdb: A database of von Hippel-Lindau protein interactors and mutations. Sci. Rep. 6, 31128 (2016).","journal-title":"Sci. Rep."},{"key":"95875_CR48","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/sj.onc.1207384","volume":"23","author":"MD Lewis","year":"2004","unstructured":"Lewis, M. D. & Roberts, B. J. Role of the C-terminal \u03b1-helical domain of the von Hippel\u2013Lindau protein in its E3 ubiquitin ligase activity. Oncogene 23, 2315\u20132323 (2004).","journal-title":"Oncogene"},{"key":"95875_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/15384047.2016.1167293","volume":"17","author":"P Yuan","year":"2016","unstructured":"Yuan, P. et al. Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family. Cancer Biol. Ther. 17, 599\u2013603 (2016).","journal-title":"Cancer Biol. Ther."},{"key":"95875_CR50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","volume":"10","author":"MA von Hoffman","year":"2001","unstructured":"von Hoffman, M. A. Hippel-Lindau protein mutants linked to type 2\u00a0C VHL disease preserve the ability to downregulate HIF. Hum. Mol. Genet. 10, 1019\u20131027 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"95875_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2018.09.004","volume":"54","author":"AN Naganathan","year":"2019","unstructured":"Naganathan, A. N. Modulation of allosteric coupling by mutations: from protein dynamics and packing to altered native ensembles and function. Curr. Opin. Struct. Biol. 54, 1\u20139 (2019).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"95875_CR52","unstructured":"Jr, W. G. K. Von Hippel\u2013Lindau disease: insights into oxygen sensing, protein degradation, and cancer. (2022). https:\/\/www.jci.org\/articles\/view\/162480\/pdf"},{"key":"95875_CR53","doi-asserted-by":"publisher","first-page":"10459","DOI":"10.1021\/jp904541g","volume":"113","author":"BA Persson","year":"2009","unstructured":"Persson, B. A., J\u00f6nsson, B. & Lund, M. Enhanced protein steering: cooperative electrostatic and Van der Waals forces in Antigen\u2009\u2013\u2009Antibody complexes. J. Phys. Chem. B. 113, 10459\u201310464 (2009).","journal-title":"J. Phys. Chem. B"},{"key":"95875_CR54","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","volume":"118","author":"HX Zhou","year":"2018","unstructured":"Zhou, H. X. & Pang, X. Electrostatic interactions in protein structure, folding, binding, and condensation. Chem. Rev. 118, 1691\u20131741 (2018).","journal-title":"Chem. Rev."},{"key":"95875_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/pro.5560010605","volume":"1","author":"A Karshikov","year":"1992","unstructured":"Karshikov, A., Bode, W., Tulinsky, A. & Stone, S. R. Electrostatic interactions in the association of proteins: an analysis of the thrombin\u2013hirudin complex. Protein Sci. 1, 727\u2013735 (1992).","journal-title":"Protein Sci."},{"key":"95875_CR56","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1021\/bi1005392","volume":"49","author":"L Baugh","year":"2010","unstructured":"Baugh, L. et al. A distal point mutation in the Streptavidin\u2009\u2013\u2009Biotin complex preserves structure but diminishes binding affinity: experimental evidence of electronic polarization effects?? Biochemistry 49, 4568\u20134570 (2010).","journal-title":"Biochemistry"},{"key":"95875_CR57","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0006-3495(96)79641-8","volume":"70","author":"CM Roth","year":"1996","unstructured":"Roth, C. M., Neal, B. L. & Lenhoff, A. M. Van der Waals interactions involving proteins. Biophys. J. 70, 977 (1996).","journal-title":"Biophys. J."},{"key":"95875_CR58","doi-asserted-by":"publisher","first-page":"20120835","DOI":"10.1098\/rsif.2012.0835","volume":"10","author":"PL Kastritis","year":"2013","unstructured":"Kastritis, P. L. & Bonvin, A. M. J. J. On the binding affinity of macromolecular interactions: daring to ask why proteins interact. J. Royal Soc. Interface. 10, 20120835 (2013).","journal-title":"J. Royal Soc. Interface"},{"key":"95875_CR59","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/pro.2330","volume":"22","author":"D Chakravarty","year":"2013","unstructured":"Chakravarty, D., Guharoy, M., Robert, C. H., Chakrabarti, P. & Janin, J. Reassessing buried surface areas in protein\u2013protein complexes. Protein Sci. 22, 1453\u20131457 (2013).","journal-title":"Protein Sci."},{"key":"95875_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.sbi.2016.12.010","volume":"44","author":"S Vishwanath","year":"2017","unstructured":"Vishwanath, S., Sukhwal, A., Sowdhamini, R. & Srinivasan, N. Specificity and stability of transient protein\u2013protein interactions. Curr. Opin. Struct. Biol. 44, 77\u201386 (2017).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"95875_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/prot.24191","volume":"81","author":"G Limaverde-Sousa","year":"2013","unstructured":"Limaverde-Sousa, G., De Andrade Barreto, E. & Ferreira, C. G. Cl\u00e1udio Casali\u2010da\u2010Rocha, J. Simulation of the mutation F76del on the von Hippel\u2013Lindau tumor suppressor protein: mechanism of the disease and implications for drug development. Proteins 81, 349\u2013363 (2013).","journal-title":"Proteins"},{"key":"95875_CR62","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min, J. H. et al. Structure of an HIF-1\u03b1-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886\u20131889 (2002).","journal-title":"Science"},{"key":"95875_CR63","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.onc.1209062","volume":"25","author":"K Knauth","year":"2006","unstructured":"Knauth, K., Bex, C., Jemth, P. & Buchberger, A. Renal cell carcinoma risk in type 2 von Hippel\u2013Lindau disease correlates with defects in pVHL stability and HIF-1\u03b1 interactions. Oncogene 25, 370\u2013377 (2006).","journal-title":"Oncogene"},{"key":"95875_CR64","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1172\/JCI8161","volume":"104","author":"M Ohh","year":"1999","unstructured":"Ohh, M. et al. Synthetic peptides define critical contacts between Elongin C, Elongin B, and the von Hippel-Lindau protein. J. Clin. Invest. 104, 1583 (1999).","journal-title":"J. Clin. Invest."},{"key":"95875_CR65","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/cancers15041316","volume":"15","author":"S Mazumder","year":"2023","unstructured":"Mazumder, S., Higgins, P. J. & Samarakoon, R. Downstream targets of VHL\/HIF-\u03b1 signaling in renal clear cell carcinoma progression: mechanisms and therapeutic relevance. Cancers 15, 1316 (2023).","journal-title":"Cancers"},{"key":"95875_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13046-021-01961-3","volume":"40","author":"R Sharma","year":"2021","unstructured":"Sharma, R. et al. Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. J. Experimental Clin. Cancer Res. 40, 186 (2021).","journal-title":"J. Experimental Clin. Cancer Res."},{"key":"95875_CR67","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12885-016-2688-0","volume":"16","author":"C Razafinjatovo","year":"2016","unstructured":"Razafinjatovo, C. et al. Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer. 16, 638 (2016).","journal-title":"BMC Cancer"},{"key":"95875_CR68","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1158\/0008-5472.CAN-11-0757","volume":"71","author":"MP Rechsteiner","year":"2011","unstructured":"Rechsteiner, M. P. et al. VHL gene mutations and their effects on hypoxia inducible factor HIF\u03b1: identification of potential driver and passenger mutations. Cancer Res. 71, 5500\u20135511 (2011).","journal-title":"Cancer Res."},{"key":"95875_CR69","first-page":"1266","volume":"20","author":"SJ Liu","year":"2018","unstructured":"Liu, S. J. et al. Genotype and phenotype correlation in von Hippel\u2013Lindau disease based on alteration of the HIF-\u03b1 binding site in VHL protein. Genet. Sci. 20, 1266\u20131273 (2018).","journal-title":"Genet. Sci."},{"key":"95875_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1582-4934.2010.01238.x","volume":"15","author":"M Li","year":"2011","unstructured":"Li, M. & Kim, W. Y. Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL. J. Cell. Mol. Med. 15, 187\u2013195 (2011).","journal-title":"J. Cell. Mol. Med."},{"key":"95875_CR71","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1158\/0008-5472.CAN-14-1161","volume":"74","author":"S Couv\u00e9","year":"2014","unstructured":"Couv\u00e9, S. et al. Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis. Cancer Res. 74, 6554\u20136564 (2014).","journal-title":"Cancer Res."},{"key":"95875_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00292-016-0171-y","volume":"37","author":"H Moch","year":"2016","unstructured":"Moch, H. [The WHO\/ISUP grading system for renal carcinoma]. Pathologe 37, 355\u2013360 (2016).","journal-title":"Pathologe"},{"key":"95875_CR73","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge, S. B. & Compton, C. C. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471\u20131474 (2010).","journal-title":"Ann. Surg. Oncol."},{"key":"95875_CR74","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452\u2013W457 (2012).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR75","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2164-14-S3-S3","volume":"14","author":"H Carter","year":"2013","unstructured":"Carter, H., Douville, C., Stenson, P. D., Cooper, D. N. & Karchin, R. Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genom. 14, S3 (2013).","journal-title":"BMC Genom."},{"key":"95875_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/humu.22965","volume":"37","author":"D Salgado","year":"2016","unstructured":"Salgado, D. et al. UMD-Predictor: A High-Throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution. Hum. Mutat. 37, 439\u2013446 (2016).","journal-title":"Hum. Mutat."},{"key":"95875_CR77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"95875_CR78","doi-asserted-by":"crossref","unstructured":"Steinhaus, R. et al. Mutation Taster Nucleic Acids Res. 49, W446\u2013W451 (2021).","DOI":"10.1093\/nar\/gkab266"},{"key":"95875_CR79","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1073\/pnas.92.2.452","volume":"92","author":"BK Shoichet","year":"1995","unstructured":"Shoichet, B. K., Baase, W. A., Kuroki, R. & Matthews, B. W. A relationship between protein stability and protein function. Proc. Natl. Acad. Sci. 92, 452\u2013456 (1995).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"95875_CR80","doi-asserted-by":"publisher","first-page":"W314","DOI":"10.1093\/nar\/gku411","volume":"42","author":"DE Pires","year":"2014","unstructured":"Pires, D. E., Ascher, D. B. & Blundell, T. L. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res. 42, W314 (2014).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR81","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296 (2018).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR82","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Science: Publication Protein Soc. 2, 1511 (1993).","journal-title":"Protein Science: Publication Protein Soc."},{"key":"95875_CR83","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/nar\/gki524","volume":"33","author":"Y Zhang","year":"2005","unstructured":"Zhang, Y. & Skolnick, J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 33, 2302 (2005).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/prot.22570","volume":"77","author":"E Krieger","year":"2009","unstructured":"Krieger, E. et al. Improving physical realism, stereochemistry and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77, 114 (2009).","journal-title":"Proteins"},{"key":"95875_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4137\/BBI.S25928","volume":"9","author":"A Sukhwal","year":"2015","unstructured":"Sukhwal, A., Sowdhamini, R. & PPCheck A webserver for the quantitative analysis of Protein\u2013Protein interfaces and prediction of residue hotspots. Bioinform. Biol. Insights. 9, 141 (2015).","journal-title":"Bioinform. Biol. Insights"},{"key":"95875_CR86","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/nar\/29.1.221","volume":"29","author":"RA Laskowski","year":"2001","unstructured":"Laskowski, R. A. PDBsum: summaries and analyses of PDB structures. Nucleic Acids Res. 29, 221 (2001).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR87","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A., Swindells, M. B. & LigPlot+ Multiple Ligand\u2013Protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"95875_CR88","doi-asserted-by":"publisher","first-page":"W338","DOI":"10.1093\/nar\/gky356","volume":"46","author":"A Kuriata","year":"2018","unstructured":"Kuriata, A. et al. CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures. Nucleic Acids Res. 46, W338 (2018).","journal-title":"Nucleic Acids Res."},{"key":"95875_CR89","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.1021\/acs.chemrev.6b00163","volume":"116","author":"S Kmiecik","year":"2016","unstructured":"Kmiecik, S. et al. Coarse-Grained protein models and their applications. Chem. Rev. 116, 7898\u20137936 (2016).","journal-title":"Chem. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95875-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95875-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95875-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T19:02:21Z","timestamp":1744743741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95875-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95875"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95875-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13022"}}